Hwang Soo-Hee, Han Seungjin, Choi Hyojung, Park Choonseon, Kim Sun Min, Kim Tae Hyun
Health Insurance Review and Assessment Service (HIRA), Wonju, Republic of Korea.
Department of Hospital Administration, Graduate School of Public Health, Institute of Health Services Research, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, 03711, Seoul, Republic of Korea.
BMC Psychiatry. 2017 Aug 22;17(1):303. doi: 10.1186/s12888-017-1467-z.
This study examined trends in the prescription of benzodiazepines for the elderly (age over 65 years) in Korea, a country with a higher level of spending on pharmaceuticals compared to that in other Organization for Economic Cooperation and Development (OECD) countries, and identified factors related to the inappropriate use of such drugs.
We used the National Health Insurance Claims Data (NHICD) for the period 2009-2013, including all reimbursed drug-prescribing information. Following the OECD's prescribing quality indicators (PQIs), we looked at the prevalence, quantities, durations, and inappropriate (long-term or high-quantity) use of benzodiazepines, some of the most widely prescribed, but potentially inappropriate, drugs for the elderly. We also performed multivariate logistic regression analyses to identify factors related to the inappropriate use of these drugs.
The annual prevalence of benzodiazepine prescribing for elderly subjects decreased slightly over time but remained high (37.9% in 2009 and 35.1% in 2013). There were also small decreases in the inappropriate long-term use of benzodiazepines over the five years, with a 0.6 decrease in the Defined Daily Dose and a 4.1 per 1,000 decreases in elderly user-days. The proportion of subjects using long-acting benzodiazepines also fell from 263.6 to 220.4 per 1,000 elderly patients. The regression analyses found that the inappropriate long-term use of benzodiazepines in the elderly was significantly related to the patients visiting several institutions and physicians prescribing more than 30 days' worth of medication.
The prevalence of prescribing potentially inappropriate drugs, such as benzodiazepines, remains high in Korea. Policy efforts, such as a periodic assessment of prescribing, restricting prescribing days, and more practical guidelines, are needed to improve the quality of prescribing.
本研究调查了韩国65岁以上老年人苯二氮䓬类药物的处方趋势。韩国在药品方面的支出水平高于其他经济合作与发展组织(经合组织)国家,并确定了与此类药物不当使用相关的因素。
我们使用了2009年至2013年期间的国民健康保险理赔数据(NHICD),其中包括所有报销的开药信息。根据经合组织的处方质量指标(PQIs),我们研究了苯二氮䓬类药物的患病率、用量、用药时长以及不当(长期或大量)使用情况。苯二氮䓬类药物是为老年人开的最常用但可能不当的药物之一。我们还进行了多因素逻辑回归分析,以确定与此类药物不当使用相关的因素。
随着时间的推移,老年受试者苯二氮䓬类药物的年处方患病率略有下降,但仍处于较高水平(2009年为37.9%,2013年为35.1%)。在这五年中,苯二氮䓬类药物的不当长期使用情况也略有下降,限定日剂量减少了0.6,老年使用者天数每千例减少了4.1。使用长效苯二氮䓬类药物的受试者比例也从每千名老年患者中的263.6降至220.4。回归分析发现,老年人苯二氮䓬类药物的不当长期使用与患者就诊多个机构以及医生开具超过30天用量的药物显著相关。
在韩国,开具潜在不当药物(如苯二氮䓬类药物)的情况仍然很普遍。需要通过定期评估处方、限制开药天数以及制定更实用的指南等政策措施来提高处方质量。